BRANFORD, Conn., Oct. 8, 2014 /PRNewswire/ — BioXcel Corporation, a pioneer in Pharma Big Data analytics solutions, today announced that Dr. Vimal Mehta, CEO and Chairman of BioXcel, will present at the 2014 Phacilitate Big Data Leaders’ Forum with AstraZeneca. The presentation will take place on October 8th, 2014 at 3:05 pm ET at the Marriott Marquis in Washington D.C. The conference will feature several keynote presentations discussing the strategic drivers of big data in fostering innovation for drug discovery and development.
BioXcel’s presentation, in collaboration with AstraZeneca, will provide a unique perspective on the challenges of World Data complexity, the adoption and implementation of big data analytics, and opportunities for value creation in pharma R&D productivity. The presentation will showcase the real-life impact of big data with case studies and discuss key trends and game changers in the space.
"Big Data in the biopharmaceutical sector is now a strategic and operational issue for stakeholders. The disruptive nature of World Data is causing a power shift in the healthcare ecosystem with the emergence of iHealth players," said Dr. Vimal Mehta. He added, "To address unmet patient needs, a strategic shift towards the integration of World Data, including behavioral, physiological, biological (genomic/genetic), clinical and patient outcomes across an organization must be implemented for the next wave of innovation."
Attendees who wish to meet with Dr. Mehta for a one-on-one meeting during the conference should contact: firstname.lastname@example.org, or call: +1-(203)-606-8041.
Please visit the conference website for the agenda (http://www.bigdataleadersforum.com/files/phacilitate_big_data_leaders_forum_2014__draft_agenda_01.10.pdf) and further details (http://www.bigdataleadersforum.com).
About BioXcel Corporation
BioXcel is a pioneer in pharma big data analytics solutions. Committed to innovation, product excellence and partner success, BioXcel has worked with over one hundred clients ranging from the world’s largest pharmaceutical to emerging biotechnology companies on mandates covering major core therapeutic areas, orphan diseases, oncology & immuno-oncology, and repurposing & reformulation opportunities. BioXcel’s unique live, first-in-class cloud based pharma big data analytics platform, PharmGPS™ revolutionizes decision making by structuring disparate data to meta-data through the application of multivariate frameworks thereby producing real time actionable insights. With experience spanning over 1 million man hours of analytics, BioXcel helps bridge the innovation to commercialization gap via its subscription based platform, product blueprint partnerships and consulting service capabilities. The Company serves a global client base and is headquartered in Branford, CT, USA with operations in Asia. Visit www.bioxcel.com for more details. Connect with PharmGPS on Twitter: @PharmGPS.